GEODE CAPITAL MANAGEMENT, LLC - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 100 filers reported holding DESIGN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,498,082
-62.7%
634,720
-0.3%
0.00%
Q2 2023$4,012,123
+9.8%
636,845
+0.6%
0.00%
Q1 2023$3,652,456
+58943.9%
633,008
+5.0%
0.00%
-100.0%
Q4 2022$6,186
-99.9%
603,013
+4.6%
0.00%0.0%
Q3 2022$9,642,000
+58.3%
576,709
+32.5%
0.00%0.0%
Q2 2022$6,091,000
+2.9%
435,125
+18.6%
0.00%0.0%
Q1 2022$5,922,000
-21.3%
366,745
+4.4%
0.00%0.0%
Q4 2021$7,524,000
+98.5%
351,441
+36.2%
0.00%0.0%
Q3 2021$3,790,000
-24.6%
258,032
+2.1%
0.00%0.0%
Q2 2021$5,027,000
+346.1%
252,760
+570.5%
0.00%
Q1 2021$1,127,00037,7000.00%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 5,626,476$78,771,00038.55%
Logos Global Management LP 2,797,501$39,165,0007.18%
Cormorant Asset Management, LP 5,500,000$77,000,0005.82%
Ghost Tree Capital, LLC 275,000$3,850,0002.00%
EcoR1 Capital, LLC 2,634,178$36,878,0001.27%
RA Capital Management 2,186,636$30,613,0000.82%
Vivo Capital, LLC 476,589$6,672,0000.67%
Avoro Capital Advisors LLC 2,222,222$31,111,0000.62%
Artal Group S.A. 400,000$5,600,0000.30%
Rock Springs Capital Management LP 460,391$6,445,0000.19%
View complete list of DESIGN THERAPEUTICS INC shareholders